Corinne Savill
Corporate Officer/Principal at CULLINAN THERAPEUTICS, INC.
Net worth: 5 M $ as of 31/05/2024
Profile
Corinne Savill is currently the Chief Business Officer at Cullinan Therapeutics, Inc. She previously held positions as the Chief Executive Officer at Imutran Ltd.
from 1997 to 2001, Director at Cantargia AB in 2018, and Global Head of Business Development & Licensing at Novartis Pharma AG from 2013 to 2017.
She also served as the Head of Business Development & Licensing at Novartis Pharmaceuticals Corp.
Dr. Savill has an undergraduate degree from The University of Manchester and a doctorate degree from Middlesex School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/02/2024 | 203,490 ( 0.35% ) | 5 M $ | 31/05/2024 |
Corinne Savill active positions
| Companies | Position | Start |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2017 |
Former positions of Corinne Savill
| Companies | Position | End |
|---|---|---|
| CANTARGIA AB | Director/Board Member | 21/05/2018 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/02/2017 |
| Imutran Ltd. | Chief Executive Officer | 01/01/2001 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Corinne Savill
| The University of Manchester | Undergraduate Degree |
| Middlesex School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CANTARGIA AB | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Imutran Ltd. | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Corinne Savill
